NCT06857331 Perioperative Analgesia With Erector Spinae Plane Block in Liver Transplant Recipients
| NCT ID | NCT06857331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bogomolets National Medical University |
| Condition | Liver Transplant |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-05-05 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-05-05 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if ESP block is safe and effective for perioperative analgesia in patients undergoing liver transplant. The main question it aims to answer are Is ESP block safe and has a minimum side effects, like hematoma? Is it effective for perioperative analgesia? Researchers will compare the results to a group of patients who underwent liver transplants without any regional anaesthesia techniques. Participants will receive bilateral thoracic ESP block on the day of the transplantation with a subsequent bilateral catheterization.
Eligibility Criteria
Inclusion Criteria: * impaired liver function - cirrhosis or chronic liver disease with the development of hypocoagulation (APTT \> 35 sec, INR \> 1.5), thrombocytopenia, patients requiring major abdominal surgery, age \> 18 years, written consent to participate in the study was obtained Exclusion Criteria: * Platelet count \<50x109, failed ESP catheterization unilateral or bilateral, failed epidural anesthesia attempt, history of allergy or hypersensitivity to local anesthetics, hepatopulmonary syndrome, patients on mechanical ventilation before surgery, patients on CRRT before surgery, refusal to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06857331 clinical trial?
This trial is open to participants of all sexes, studying Liver Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06857331 currently recruiting?
Yes, NCT06857331 is actively recruiting participants. Contact the research team at n.mysynchuk@oberig.ua for enrollment information.
Where is the NCT06857331 trial being conducted?
This trial is being conducted at Kyiv, Ukraine.
Who is sponsoring the NCT06857331 clinical trial?
NCT06857331 is sponsored by Bogomolets National Medical University. The trial plans to enroll 50 participants.